NCT03878420 (LIGHTSITE II).

Study name	Study of Photobiomodulation to Treat Dry Age‐Related Macular Degeneration (LIGHTSITE II)
Methods	Double‐masked randomised sham‐controlled
Participants	Non‐exudative age‐related macular degeneration
Interventions	The Valeda™ Light Delivery System delivering 590, 660 and 850nm wavelengths together or the Valeda™ Light Delivery System delivering non‐effective treatment of the 590 and 660nm wavelengths together
Outcomes	Primary: change from baseline of best‐corrected visual acuity at 9 months Secondary: mean difference of best‐corrected visual acuity contrast sensitivity central drusen volume central drusen thickness
Starting date	February 2019
Contact information	Clark Tedford ctedford@lumithera.com
Notes